GMED
Globus Medical Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 9/10
- Value↓ 4/10
GMED Growth
- Revenue Y/Y↑ 16.65%
- EPS Y/Y↑ 423.68%
- FCF Y/Y↑ 45.30%
GMED Profitability
- Gross margin ↑ 67.40%
- EPS margin↑ 18.30%
- ROIC 5Y↑ 12.58%
GMED Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↑ 83.7
Globus Medical stock volatility is in-line with the overall market. We give it a Great risk rating.